Company Overview of Novo A/S
Novo A/S is a private equity and venture capital arm of The Novo Nordisk Foundation specializing in direct and secondary direct investments. Within direct, it seeks to make private equity and venture capital investments in development stage companies in the form of seed, start up, early venture, mid venture, late venture, growth equity, mature, later stage, and mezzanine investments. It also provides pre-seed grants for early stage projects. The firm seeks to invest in biotechnology, healthcare, and life sciences companies with a focus on investments in products for diagnosis, control, treatment, and prevention of disease; development and application of biotechnology; instruments and medical...
Tuborg Havnevej 19
Founded in 1999
Key Executives for Novo A/S
Senior Partner of Novo Ventures (US) Inc.
Head of Large Investments
Compensation as of Fiscal Year 2015.
Novo A/S Key Developments
Novo A/S Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 through Sep-30-2015
Jul 31 15
Novo A/S Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 through Sep-30-2015. Venue: Congress Center, Basel, Switzerland. Presentation Date & Speakers: Sep-29-2015, Nanna Lüneborg, Investment Director, Søren Møller.
Novo A/S Presents at Bio-Trinity, May-11-2015
Apr 29 15
Novo A/S Presents at Bio-Trinity, May-11-2015 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.
Novo ventures Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-05-2015 12:00 PM
Apr 27 15
Novo ventures Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-05-2015 12:00 PM. Venue: Sheraton Centre Toronto Hotel (Corner of York and Queen St. West), Toronto, Ontario, M5H 3M9, Canada. Speakers: Eric Shiozaki.
Similar Private Companies By Industry
Recent Private Companies Transactions